These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. 21st century drug development: advances, opportunities and challenges. Bhogal N Altern Lab Anim; 2009 Sep; 37(4):335-9. PubMed ID: 19807207 [No Abstract] [Full Text] [Related]
9. Observations on screening-based research and some concerning trends in the literature. Baell JB Future Med Chem; 2010 Oct; 2(10):1529-46. PubMed ID: 21426147 [TBL] [Abstract][Full Text] [Related]
11. Forging synergies in drug discovery. Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672 [No Abstract] [Full Text] [Related]
12. Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro-in vivo correlation. Somayaji MR; Das D; Przekwas AJ Drug Discov Today; 2018 Sep; 23(9):1571-1573. PubMed ID: 29428643 [No Abstract] [Full Text] [Related]
13. HPLC-MS/MS in drug metabolism and pharmacokinetic screening. Hsieh Y Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):93-101. PubMed ID: 18370861 [TBL] [Abstract][Full Text] [Related]
14. From fragment to clinical candidate--a historical perspective. Chessari G; Woodhead AJ Drug Discov Today; 2009 Jul; 14(13-14):668-75. PubMed ID: 19427404 [TBL] [Abstract][Full Text] [Related]
15. From in vivo to in vitro/in silico ADME: progress and challenges. Van de Waterbeemd H Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647 [TBL] [Abstract][Full Text] [Related]
16. Chirality in new drug development. Clinical pharmacokinetic considerations. Nation RL Clin Pharmacokinet; 1994 Oct; 27(4):249-55. PubMed ID: 7834962 [No Abstract] [Full Text] [Related]
17. Emerging technologies for the study of drug metabolism and pharmacokinetics. Hsieh Y Curr Drug Discov Technol; 2010 Sep; 7(3):141-2. PubMed ID: 20843297 [No Abstract] [Full Text] [Related]
18. Correct assessment of new compounds using in vivo screening models can reduce false positives. Bueters TJ; Hoogstraate J; Visser SA Drug Discov Today; 2009 Jan; 14(1-2):89-94. PubMed ID: 18840543 [TBL] [Abstract][Full Text] [Related]
19. [Strategy of molecular drug design: hits, leads and drug candidates]. Guo ZR Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779 [TBL] [Abstract][Full Text] [Related]
20. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. Roberts SA Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]